Gedeon Richter Is Latest To File European Denosumab

Follows Closely Behind Fresenius Submission To EMA For Prolia/Xgeva Rivals

 
• By Dave Wallace

Gedeon Richter has revealed that its European filing for a denosumab biosimilar rival to Prolia/Xgeva has been accepted for review by the EMA.

EU flag on file folder
Richter’s filing has been accepted by the EMA • Source: Shutterstock

More from Biosimilars

More from Products